USA flag logo/image

An Official Website of the United States Government

DEVELOPMENT OF A LIPOSOME BASED INTRAMUSCULAR SUSTAINED RELE

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
2937
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
2937
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Liposome Technology Inc
1050 Hamilton Court Menlo Park, CA 94025
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1986
Title: DEVELOPMENT OF A LIPOSOME BASED INTRAMUSCULAR SUSTAINED RELE
Agency: HHS
Contract: N/A
Award Amount: $500,000.00
 

Abstract:

A LIPOSOME BASED SUSTAINED RELEASE DELIVERY SYSTEM FOR I.M. INJECTION OF WATER SOLUBLE DRUGS WAS DEVELOPED USING GENTAMICIN (I) AS A MODEL DRUG. THE PHARMACOKINETIC PROFILE OF (I) IN MICE, BIODEGRADATION OF THE CARRIER AT THE SITE OF INJECTION, AND HISTOLOGICAL EFFECTS WERE INVESTIGATED. THREE TYPES OF LIPOSOMAL CARRIERS WITH DIFFERENT RELEASE CHARACTERISTICS WERE TESTED. PEAK PLASMA CONCENTRATIONS OF COMPARABLE DOSES OF (I), IN LIPOSOMES OR AS SOLUTION, WERE REDUCED 2.575 TIMES WHEN GIVEN ENCAPSULATED. PROLONGED PLASMA LEVELS OVER AT LEAST 4 HOURS WERE ACHIEVED WITH ENCAPSULATED (I), WHEREAS A COMPARABLE DOSE OF (I) IN SOLUTION WAS ELIMINATED FROM PLASMA WITHIN 2 HOURS. THE CARRIER WAS SLOWLY DEGRADED IN MUSCLE OVER SEVERAL DAYS. BOTH DRUG INPUT AND DEGRADATION RATE WERE A FUNCTION OF LIPOSOME COMPOSITION. THE CARRIER WAS FOUND NO MORE IRRITATING TO MUSCLE TISSUE THAN SALINE. NO ADVERSE HISTOLOGICAL REACTION WAS FOUND OVER 14 DAYS. PHARMACOKINETIC MODELING INDICATED THAT DRUG INPUT CAN BE TAILORED OVER A WIDE RANGE. CLINICALLY, DOSAGE FREQUENCY MAY BE REDUCED TO ONE DAILY INJECTION AND LESS FLUCTUATION OF PLASMA LEVELS, REDUCTION OF SIDE EFFECTS, AND IMPROVED PATIENT COMPLIANCE MAY BE EXPECTED. IN PHASE II, EFFICACY AND TOXICITY STUDIES IN ANIMALS AND PRODUCTION OF PILOT BATCHES TO SUPPORT PRECLINICAL AND CLINICAL STUDIES

Principal Investigator:

Hans Schreier
Principal Investigator
4153239011

Business Contact:

Small Business Information at Submission:

Liposome Technology, Inc.
1050 Hamilton Court Menlo Park, CA 94025

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No